Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system.
Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients.
SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is available immediately to more than 9,000 U.S. healthcare through the Nuance AI Marketplace, a workflow-integrated cloud platform for diagnostic imaging AI algorithms.
Nuance Communications, which Microsoft is acquiring, and Olympus’ AI-based SeleCT analysis partner Imbio helped create the SeleCT Connect program.
SeleCT Connect automatically sends CT studies directly from physicians and radiologists’ picture archive and communication system (PACS) to the SeleCT QCT analysis service. Results automatically return to the patient record f…